- Home
- MMLP vs TLSI Comparison
MMLP vs TLSI Comparison
Compare MMLP & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMLP
- TLSI
- Stock Information
- Founded
- MMLP 2002
- TLSI 2010
- Country
- MMLP United States
- TLSI United States
- Employees
- MMLP N/A
- TLSI N/A
- Industry
- MMLP Oil Refining/Marketing
- TLSI Medical Specialities
- Sector
- MMLP Energy
- TLSI Health Care
- Exchange
- MMLP Nasdaq
- TLSI Nasdaq
- Market Cap
- MMLP 139.6M
- TLSI 160.4M
- IPO Year
- MMLP 2002
- TLSI N/A
- Fundamental
- Price
- MMLP $3.60
- TLSI $5.52
- Analyst Decision
- MMLP
- TLSI Strong Buy
- Analyst Count
- MMLP 0
- TLSI 6
- Target Price
- MMLP N/A
- TLSI $11.75
- AVG Volume (30 Days)
- MMLP 117.0K
- TLSI 67.6K
- Earning Date
- MMLP 04-16-2025
- TLSI 03-27-2025
- Dividend Yield
- MMLP 0.57%
- TLSI N/A
- EPS Growth
- MMLP N/A
- TLSI N/A
- EPS
- MMLP N/A
- TLSI N/A
- Revenue
- MMLP $707,622,000.00
- TLSI $29,431,000.00
- Revenue This Year
- MMLP $4.19
- TLSI $55.43
- Revenue Next Year
- MMLP N/A
- TLSI $50.09
- P/E Ratio
- MMLP N/A
- TLSI N/A
- Revenue Growth
- MMLP N/A
- TLSI 58.99
- 52 Week Low
- MMLP $2.36
- TLSI $3.50
- 52 Week High
- MMLP $4.13
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- MMLP 45.38
- TLSI 52.49
- Support Level
- MMLP $3.44
- TLSI $5.23
- Resistance Level
- MMLP $3.74
- TLSI $5.72
- Average True Range (ATR)
- MMLP 0.19
- TLSI 0.35
- MACD
- MMLP -0.02
- TLSI 0.02
- Stochastic Oscillator
- MMLP 34.78
- TLSI 78.72
About MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.